Dr. McCallum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
490 Lapp Road
Malvern, PA 19355
Summary
- Dr. Stewart McCallum is a urology specialist based in Malvern, PA. He completed his medical studies in 1992 at the University of Toronto Faculty of Medicine, followed by a residency in Urology at the University of Toronto and a Fellowship at New York Presbyterian Hospital (Cornell Campus) from 1992 to 1998. He is a consultant chief medical officer with expertise in translational medicine. He is highly experienced at all stages of clinical development, from first-in-human clinical trials through phase III to file approval and launch across various indications. He is a Fellow of the American College of Surgeons and a member of the Royal College of Surgeons Canada.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1997 - 1998
- University of TorontoResidency, Urology, 1992 - 1997
- University of Toronto Faculty of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 1998 - 2025
- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Evaluation of N1539 Following Bunionectomy Surgery Start of enrollment: 2016 Jan 01
- Evaluation of N1539 Following Major Surgery Start of enrollment: 2016 Mar 01
- Evaluation of Preoperative N1539 in Colorectal Surgery Start of enrollment: 2017 Oct 24
- Join now to see all
Publications & Presentations
PubMed
- Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study.Richard D Berkowitz, Richard Steinfeld, Alexander P. Sah, Vamshi Ruthwik Anupindi, Drishti Shah
Journal of Pain & Palliative Care Pharmacotherapy. 2021-07-19 - 7 citationsSafety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.Richard D Berkowitz, Richard Steinfeld, Alexander P. Sah, Randall J Mack, Stewart W. McCallum
Pain Medicine. 2021-06-04 - 11 citationsMeloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain.Richard D Berkowitz, Randall J Mack, Stewart W. McCallum
Pain Management. 2021-05-01
Press Mentions
- Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain MedicineApril 26th, 2021
- Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC AnesthesiologyNovember 20th, 2020
- Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific MeetingJuly 30th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: